BSX
Price
$88.99
Change
+$0.33 (+0.37%)
Updated
Dec 20, 04:59 PM (EDT)
38 days until earnings call
EW
Price
$74.81
Change
+$0.88 (+1.19%)
Updated
Dec 20 closing price
39 days until earnings call
Ad is loading...

BSX vs EW

Header iconBSX vs EW Comparison
Open Charts BSX vs EWBanner chart's image
Boston Scientific
Price$88.99
Change+$0.33 (+0.37%)
Volume$70.31K
CapitalizationN/A
Edwards Lifesciences
Price$74.81
Change+$0.88 (+1.19%)
Volume$14.21M
CapitalizationN/A
BSX vs EW Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. EW commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and EW is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (BSX: $88.95 vs. EW: $74.81)
Brand notoriety: BSX and EW are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 260% vs. EW: 266%
Market capitalization -- BSX: $100.1B vs. EW: $57.52B
BSX [@Medical Specialties] is valued at $100.1B. EW’s [@Medical Specialties] market capitalization is $57.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileEW’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • EW’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than EW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while EW’s TA Score has 6 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • EW’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BSX and EW are a good buy in the short-term.

Price Growth

BSX (@Medical Specialties) experienced а -1.29% price change this week, while EW (@Medical Specialties) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

BSX is expected to report earnings on Jan 29, 2025.

EW is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than EW($57.5B). BSX has higher P/E ratio than EW: BSX (63.64) vs EW (40.98). BSX YTD gains are higher at: 53.866 vs. EW (-1.889). BSX has higher annual earnings (EBITDA): 3.45B vs. EW (1.76B). EW has more cash in the bank: 1.64B vs. BSX (865M). EW has less debt than BSX: EW (695M) vs BSX (9.49B). BSX has higher revenues than EW: BSX (14.2B) vs EW (6.01B).
BSXEWBSX / EW
Capitalization100B57.5B174%
EBITDA3.45B1.76B196%
Gain YTD53.866-1.889-2,852%
P/E Ratio63.6440.98155%
Revenue14.2B6.01B236%
Total Cash865M1.64B53%
Total Debt9.49B695M1,366%
FUNDAMENTALS RATINGS
BSX vs EW: Fundamental Ratings
BSX
EW
OUTLOOK RATING
1..100
8132
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
7219
PRICE GROWTH RATING
1..100
4350
P/E GROWTH RATING
1..100
3083
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (80) in the Medical Specialties industry is in the same range as EW (87). This means that BSX’s stock grew similarly to EW’s over the last 12 months.

BSX's Profit vs Risk Rating (10) in the Medical Specialties industry is significantly better than the same rating for EW (100). This means that BSX’s stock grew significantly faster than EW’s over the last 12 months.

EW's SMR Rating (19) in the Medical Specialties industry is somewhat better than the same rating for BSX (72). This means that EW’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Price Growth Rating (43) in the Medical Specialties industry is in the same range as EW (50). This means that BSX’s stock grew similarly to EW’s over the last 12 months.

BSX's P/E Growth Rating (30) in the Medical Specialties industry is somewhat better than the same rating for EW (83). This means that BSX’s stock grew somewhat faster than EW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXEW
RSI
ODDS (%)
Bearish Trend 3 days ago
41%
Bearish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
62%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
68%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 5 days ago
48%
Bearish Trend 14 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Ad is loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMN0.920.02
+1.88%
ProMIS Neurosciences
BKR40.320.52
+1.31%
Baker Hughes Company
DNB12.360.14
+1.15%
Dun & Bradstreet Holdings
KRP15.410.03
+0.20%
Kimbell Royalty Partners LP
TATT26.00-0.16
-0.61%
TAT Technologies Ltd

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with SYK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.33%
SYK - BSX
58%
Loosely correlated
+2.09%
ISRG - BSX
53%
Loosely correlated
+0.10%
RVTY - BSX
52%
Loosely correlated
+1.83%
EW - BSX
44%
Loosely correlated
+1.19%
ITGR - BSX
35%
Loosely correlated
+0.59%
More